Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

85 Results

Guidelines and Advice

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Status: Archived
ID: 6-22

Jan 2007

Guidelines and Advice

The Role of Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

Status: Archived
ID: CED 4

May 2007

Guidelines and Advice

The Role of Albumin-bound Paclitaxel (Abraxane) in the Treatment of Metastatic Breast Cancer

Status: Archived
ID: CED 6

Jun 2007

Guidelines and Advice

Guidance on the Substitution of Systemic Therapy Agents

Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Guidelines and Advice

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Status: Current
ID: GL-C50-30

Feb 2017

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Apr 2017

Guidelines and Advice

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Status: Archived
ID: 7-4
Version: 2

Dec 2017

Guidelines and Advice

Iodine-131 Tositumomab in Lymphoma

Status: Archived
ID: 6-19

Jan 2007

Cancer facts

Reported Tobacco Screening Increases among New Cancer Patients

Jan 2017

Cancer facts

Cancer rates increasing among children in Ontario

Nov 2017

Guidelines and Advice

Postoperative Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer: Guidance for Nurses

Status: Archived
ID: 7-1-2N

Dec 2007

Cancer facts

Ontario Cancer Profiles Lets You Explore Cancer Statistics

Aug 2017

Pages